Consumer Products
Retail
US
Marker Therapeutics
$5.509876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.53 (-8.79%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell MRKR and other stocks, options, ETFs, and crypto commission-free!
About MRKR
Marker Therapeutics, Inc. Common Stock, also called Marker Therapeutics, is a clinical-stage immuno-oncology company, which specializes in the development and commercialization of novel cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Read More The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Employees
11
Headquarters
Houston, Texas
Founded
1991
Market Cap
274.27M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.11M
High Today
$5.88
Low Today
$5.43
Open Price
$5.81
Volume
1.24M
52 Week High
$10.60
52 Week Low
$4.18
Collections
Consumer Products
Retail
US
North America
Price Paid on Robinhood
16% Lower
Right Now
52 Week Low
$2.65
Average Price Paid
$6.52
52 Week High
$13.55
MRKR Earnings
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 8, After Hours